Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
autoimmune disease
muscular dystrophy |
| gptkbp:affects |
bulbar muscles
limb muscles neuromuscular junction ocular muscles respiratory muscles |
| gptkbp:associatedWith |
thymoma
|
| gptkbp:canBeAutoimmune |
yes
|
| gptkbp:canBeCongenital |
yes
|
| gptkbp:canBeExacerbatedBy |
beta blockers
magnesium quinidine aminoglycoside antibiotics |
| gptkbp:cause |
gptkb:myasthenic_crisis
|
| gptkbp:causedBy |
autoantibodies against acetylcholine receptor
|
| gptkbp:characterizedBy |
muscle weakness
fatigability |
| gptkbp:diagnosedBy |
electromyography
anti-acetylcholine receptor antibody test edrophonium test |
| gptkbp:firstDescribed |
gptkb:Thomas_Willis
1672 |
| https://www.w3.org/2000/01/rdf-schema#label |
Myasthenia gravis
|
| gptkbp:ICD-10_code |
G70.0
|
| gptkbp:MeSH_ID |
D009157
|
| gptkbp:OMIM |
254200
|
| gptkbp:prevalence |
about 20 per 100,000 people
|
| gptkbp:riskFactor |
female sex (under 40)
male sex (over 60) |
| gptkbp:subspecies |
gptkb:ocular_myasthenia_gravis
MuSK antibody myasthenia gravis generalized myasthenia gravis seronegative myasthenia gravis |
| gptkbp:symptom |
difficulty breathing
ptosis dysphagia diplopia dysarthria |
| gptkbp:treatment |
acetylcholinesterase inhibitors
corticosteroids immunosuppressants intravenous immunoglobulin plasmapheresis thymectomy |
| gptkbp:triggeredBy |
certain medications
stress infection |
| gptkbp:bfsParent |
gptkb:Benzodiazepines
gptkb:Madame_Web |
| gptkbp:bfsLayer |
6
|